Skip to main content
Ipsen logo

Ipsen — Investor Relations & Filings

Ticker · IPN ISIN · FR0010259150 LEI · 549300M6SGDPB4Z94P11 PA Manufacturing
Open in API
Filings indexed 1,378 across all filing types
Latest filing 2019-11-05 Board/Management Inform…
Country FR France
Listing PA IPN

About Ipsen

https://www.ipsen.com/

Ipsen is a global biopharmaceutical company focused on innovation and specialty care. The company develops and commercializes transformative medicines to address high unmet medical needs in three key therapeutic areas: oncology, rare diseases, and neuroscience. By leveraging its specialized expertise and strategic partnerships, Ipsen aims to accelerate the development of new therapies and improve health outcomes for patients worldwide. Its strategy is centered on advancing science with purpose to bring innovative treatments from research and development to the market.

Recent filings

Filing Released Lang Actions
Informations privilégiées / Autres communiqués
Board/Management Information Classification · 1% confidence The document is a press release announcing a significant change in senior management: the appointment of Dr. Howard Mayer as Executive Vice-President, Head of Research & Development, effective December 1, 2019. This directly corresponds to the definition of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management. The document is not a full financial report (10-K or IR), an earnings release (ER), or a proxy statement (DEF 14A/PSI).
2019-11-05 French
Inside Information / Other news releases
Board/Management Information Classification · 1% confidence The document is a press release dated November 5, 2019, announcing the appointment of Dr. Howard Mayer as Executive Vice President and Head of Research and Development. This content specifically deals with changes in senior management personnel. Based on the provided definitions, this aligns directly with the 'Board/Management Information' category.
2019-11-05 English
Informations privilégiées / Autres communiqués
M&A Activity Classification · 1% confidence The document is a press release dated November 5, 2019, from Ipsen concerning a proposed restructuring (scission/reclassement de titres) by its controlling shareholder, Mayroy, and the subsequent filing of an application for exemption from a mandatory public takeover bid (offre publique) with the AMF (Autorité des Marchés Financiers). This announcement details changes in shareholding structure and control mechanisms among related parties (Anne and Henri Beaufour families). This type of corporate action, involving changes in control, shareholding thresholds, and regulatory filings related to takeover rules, most closely aligns with announcements regarding capital structure changes or significant ownership notifications. Since it explicitly discusses the control structure change and the filing of a request for exemption from a mandatory tender offer due to crossing voting thresholds, it relates to the structure of share ownership and potential transactions. While it touches upon shareholding changes (MRQ), the core subject is a major corporate transaction (restructuring of the controlling entity) that triggers mandatory reporting requirements concerning control and potential takeovers. Given the options, 'Share Issue/Capital Change' (SHA) is a possibility if the restructuring is viewed as a capital structure event, but 'Major Shareholding Notification' (MRQ) is often used for threshold crossings resulting from such events. However, the document is fundamentally about a corporate transaction (restructuring of the holding company Mayroy) that impacts control and triggers a regulatory filing regarding a mandatory offer exemption. This is a significant corporate event announcement. Since it is not a standard financial report (10-K, IR, ER) or a management/board change, and it deals with the structure of ownership and control, it fits best under a category related to capital or ownership structure changes. Given the context of restructuring the controlling shareholder's holdings and the resulting filing with the AMF regarding the mandatory offer exemption, this is a significant corporate action announcement. 'SHA' (Share Issue/Capital Change) covers capital structure changes, which this restructuring implies. 'MRQ' covers major shareholding notifications (threshold crossings). Since the primary driver is the restructuring of the controlling entity's holdings leading to threshold crossings and the associated regulatory filing, 'MRQ' (Major Shareholding Notification) is a strong candidate, as is 'CAP' (Capital/Financing Update) if the restructuring is viewed broadly as a capital structure event. Given the focus on the controlling shareholder's holdings and the resulting threshold crossings, MRQ is the most precise fit among the ownership-related codes, although it is not a typical notification *by* a shareholder crossing a threshold, but rather an announcement *about* the transaction causing it. If we consider the nature of the transaction (restructuring of control), it is a significant corporate event. In the absence of a specific 'Control Change' code, and noting the discussion of shareholding percentages and threshold crossings, MRQ is selected as the closest fit for significant ownership structure changes being announced by the company. Revisiting the definitions: MRQ is 'Notification of changes in significant share ownership levels (crossing thresholds)'. This document announces the *reason* for the crossing and the subsequent regulatory filing. This is a high-level corporate announcement about ownership structure change. Let's check TAR (M&A Activity) - not applicable. Let's check SHA (Share Issue/Capital Change) - restructuring of the holding company's assets (Ipsen shares) is a capital structure change for the holding entity, which impacts Ipsen's control structure. Given the complexity and the focus on the control structure simplification, SHA seems slightly broader and more appropriate for a major restructuring announcement than MRQ, which usually implies a direct filing from the shareholder crossing the threshold. I will classify this as a Capital/Financing Update (CAP) or Share Issue/Capital Change (SHA). Since it is a restructuring of ownership/control, SHA is the best fit for a capital structure event impacting control.
2019-11-05 French
Inside Information / Other news releases
M&A Activity Classification · 1% confidence The document discusses a proposed reclassification of shares held by the controlling shareholder, Mayroy, which involves a demerger and subsequent request for a waiver from the obligation to file a public offer with the AMF (Autorité des Marchés Financiers). This action directly relates to changes in ownership structure, control, and potential mandatory takeover bids triggered by crossing ownership thresholds. This subject matter aligns most closely with corporate actions affecting share capital and control, which often fall under financing/capital structure updates or major shareholding notifications. However, the core event is the restructuring of the controlling shareholder's holdings and the resulting regulatory filing (waiver request) concerning the obligation to launch a public offer. This is a significant event related to capital structure and control, but it is not a standard financing announcement (CAP) or a simple notification of a change in a major shareholder's stake (MRQ). It is a specific regulatory filing concerning a change in control structure due to internal restructuring. Given the options, 'Capital/Financing Update' (CAP) covers structural changes, but the context is heavily focused on the regulatory filing regarding the public offer obligation resulting from the shareholding change. Since the document details the structure change and the regulatory filing to avoid a mandatory offer, it is best classified as a significant event impacting the capital structure and control, fitting best under 'Capital/Financing Update' (CAP) or potentially 'Major Shareholding Notification' (MRQ) due to the crossing of thresholds. Since the primary driver is the restructuring leading to the waiver request, CAP is a strong fit for structural changes. However, the document explicitly mentions that 'thresholds will be crossed by the holding companies belonging to persons acting in concert' and a request for a waiver was filed. This is a direct consequence of a change in shareholding percentage crossing regulatory limits. Therefore, 'Major Shareholding Notification' (MRQ) is highly relevant, although the event is more complex than a simple notification. Given the focus on the ownership structure change and the resulting regulatory filing concerning the public offer obligation, this is a significant corporate action related to ownership control. Let's re-evaluate: It's not a standard ER, 10-K, or IR. It's not a dividend (DIV) or management change (MANG). It is about shareholding structure and regulatory compliance related to control. 'MRQ' covers changes in significant share ownership levels. This event is a direct result of such a change crossing a threshold. I will classify it as MRQ as it centers on the change in ownership structure and the resulting regulatory consequence.
2019-11-05 English
Informations privilégiées / Autres communiqués
Regulatory Filings Classification · 1% confidence The document is a press release dated October 31, 2019, announcing that Ipsen will present new data (a network meta-analysis and a budget impact analysis) at the ISPOR Europe 2019 conference in November 2019. The text details the content of the presentations, quotes executives, and provides a schedule of the presentations. It is not the full Annual Report (10-K), an Interim Report (IR), or a Call Transcript (CT). It is an announcement about upcoming presentations of research findings, which aligns best with an Investor Presentation (IP) or a general announcement. Since the core purpose is to inform investors and the public about data being presented at a major industry conference, 'Investor Presentation' (IP) is a strong candidate, as these press releases often accompany or precede investor-focused materials. However, the document itself is a press release announcing *future* presentations, not the presentation slides themselves. Given the options, and recognizing that this is a formal communication detailing scientific/economic data to be shared with stakeholders, it functions as a precursor to investor information. If the document were the actual presentation slides, IP would be correct. As it is a press release announcing the presentation of data, it is a form of corporate communication. Since it details specific scientific/economic analyses intended for market access and investor audiences, 'Investor Presentation' (IP) is the most fitting category among the choices for content focus, even if it's the announcement *of* the presentation rather than the slides themselves. It is not a general Regulatory Filing (RNS) because it fits the IP content profile better. It is not an Earnings Release (ER) as it discusses research data, not financial results.
2019-10-31 French
Inside Information / Other news releases
Investor Presentation Classification · 1% confidence The document is a press release from Ipsen dated October 31, 2019, announcing that results from a network meta-analysis (NMA) and a budget impact study will be presented at the ISPOR Europe 2019 conference. It details the content of these presentations, which involve clinical and economic data for their drugs (Cabometyx and Somatuline). The text also includes extensive product information (SmPC/PI excerpts) for CABOMETYX®, covering indications, dosage, warnings, and adverse reactions. This structure—announcing participation in a scientific/investor event while providing detailed product/clinical data—is characteristic of an Investor Presentation (IP) or a detailed press release accompanying such an event, rather than a formal regulatory filing like a 10-K, ER, or IR. Since it is a detailed presentation of strategy, data, and product information aimed at investors and healthcare leaders attending a conference, 'Investor Presentation' (IP) is the most fitting category, even though it is delivered via a press release format.
2019-10-31 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.